Uncategorized

Eli Lilly acquires biotech firm Dice Therapeutics for $2.4 billion

The pharmaceutical industry encompasses more than just weight-loss drugs. Eli Lilly, a prominent drug-making company, announced on Tuesday that it has agreed to acquire Dice Therapeutics, a specialized firm that focuses on developing oral treatments for autoimmune diseases. The deal,

The pharmaceutical industry encompasses more than just weight-loss drugs. Eli Lilly, a prominent drug-making company, announced on Tuesday that it has agreed to acquire Dice Therapeutics, a specialized firm that focuses on developing oral treatments for autoimmune diseases. The deal, […]

Read More 

Leave a Reply

Your email address will not be published. Required fields are marked *

Scroll to top
Generated by Feedzy